Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer and Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07523529
What this trial is testing

Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors

Who this might be right for
Advanced UnresectableMetastatic
Beijing Biotech 72
Early research (Phase 1)Looking for participantsNCT06910657
What this trial is testing

IDOV-Immune for Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerMelanoma+13 more
ViroMissile, Inc. 78
Large-scale testing (Phase 3)Study completedNCT00270166
What this trial is testing

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

Who this might be right for
AnemiaMultiple MyelomaLymphoma+6 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Not applicableStudy completedNCT00005956
What this trial is testing

Biological Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerGastric CancerOvarian Cancer
Duke University 3
Not applicableStudy completedNCT05306002
What this trial is testing

Nutritional Intervention and DNA Damage of Patients With HBOC

Who this might be right for
HBOC SyndromeDNA DamageNutrition Therapy
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado 34
Post-approval studies (Phase 4)Study completedNCT04024254
What this trial is testing

Serum Folate Levels in Patients Treated With Olaparib

Who this might be right for
Ovarian CancerBreast CancerFolic Acid Deficiency
Rush University Medical Center 10
Very early researchActive Not RecruitingNCT04147494
What this trial is testing

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Who this might be right for
Breast CarcinomaColon CarcinomaEsophageal Carcinoma+8 more
Jonsson Comprehensive Cancer Center 29
Early research (Phase 1)Looking for participantsNCT05005403
What this trial is testing

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Who this might be right for
Non-Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMicro Satellite Stable Colorectal Cancer+4 more
AbbVie
Early research (Phase 1)Study completedNCT03199586
What this trial is testing

Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

Who this might be right for
Breast CancerPancreas CancerProstate Cancer+6 more
Novita Pharmaceuticals, Inc. 23
Testing effectiveness (Phase 2)Looking for participantsNCT07109726
What this trial is testing

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Who this might be right for
Breast CancerEndometrial CancerOvarian Cancer+5 more
Terremoto Biosciences Inc. 205
Not applicableNot Yet RecruitingNCT07160010
What this trial is testing

Clinical Validation of Sophia Genetics Assay

Who this might be right for
Ovarian CancerBreast CancerLynch Syndrome+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 248
Not applicableStudy completedNCT03198286
What this trial is testing

Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors

Who this might be right for
Stage I Breast CancerStage I Cervical CancerStage I Ovarian Cancer+36 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 40
Not applicableStudy completedNCT04066361
What this trial is testing

OPTimizing Treatment Focused Genetic Testing IN Cancer

Who this might be right for
Breast CancerOvarian CancerPancreatic Cancer+1 more
Dana-Farber Cancer Institute 301
Testing effectiveness (Phase 2)Study completedNCT00196846
What this trial is testing

Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 62
Early research (Phase 1)Active Not RecruitingNCT05215574
What this trial is testing

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 130
Large-scale testing (Phase 3)Active Not RecruitingNCT03937154
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen 145
Not applicableUnknownNCT02745262
What this trial is testing

Overall Survival and Disease-free Survival in Breast Cancer Patients Under COS

Who this might be right for
Breast Cancer
IVI Vigo 400
Early research (Phase 1)Study completedNCT01831089
What this trial is testing

Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors

Who this might be right for
Breast CancerOvarian CancerGynecological Cancer+4 more
PharmaMar 69
Post-approval studies (Phase 4)Study completedNCT00190697
What this trial is testing

LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Who this might be right for
Breast CancerEndometrial CancerOvarian Cancer
Eli Lilly and Company 70
Early research (Phase 1)Study completedNCT00313599
What this trial is testing

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more
University of California, San Francisco 28
Next Page
694